FDA | What's New 中文 关注 FDA关于哌拉西林-他唑巴坦与铜绿假单胞菌断点识别的理由 FDA Rationale for Breakpoints Recognition Decision: Piperacillin-Tazobactam and Pseudomonas aeruginosa fda.gov
